Description
OZOVIT MP
Dust
Description
Medical device containing, as an active substance, magnesium peroxide (not less than 25% MgO 2 ) which develops oxygen in the gastrointestinal tract. This development of oxygen is accompanied by a significant reduction in intestinal germs which are present in high numbers in acute and chronic intestinal pathologies (dysbiosis).
Ozovit MP is therefore used in cases of gastrointestinal disorders caused by abnormal fermentation and putrefaction. Ozovit MP has been found to be effective as a preliminary disinfectant of the intestinal tract in cases of dysbiosis. In intestinal mycoses, specific antifungal treatment should precede the use of Ozovit MP, since the activity on fungi and protozoa has been found to be cytostatic.
Ozovit is a saline laxative with osmotic action. Since the absorption of magnesium peroxide is difficult, it results in water retention and an increase in water in the intestinal lumen. The intestinal contents become more voluminous, resulting in increased peristalsis.
Ozovit MP is indicated in episodes of occasional constipation and as a bowel movement aid before diagnostic tests or particular therapeutic treatments.
Composition
100 g contains: 100 g of magnesium peroxide.
How to use
Adults: 1 to 3 scoops of powder in water or fruit juice, 2 times a day 1 hour after meals.
In case of severe diarrhea, reduce the dosage or suspend treatment for 2-3 days. Then resume administration at a lower dosage.
Warnings
Ozovit MP should not be used for more than a week.
Do not take in case of renal insufficiency and intestinal obstruction (ileus). Do not take in case of known hypersensitivity to magnesium peroxide. Do not administer to children and adolescents. In rare cases, side effects may occur severe diarrhea with intestinal cramps and loss of electrolytes. These can be avoided by reducing the dosage.
Interactions with other drugs: in general, in order not to impair absorption, an interval of 1-2 hours must be respected between the administration of Ozovit MP and the following substances: iron, tetracyclines, sodium fluoride, isoniazid, chlorpromazine and digoxin.
As with other laxatives, prolonged intake of Ozovit MP can cause loss of water, potassium and other salts, resulting in cardiac function disorders and myasthenia. For this reason, the duration of administration should be limited to one week.
Format
100g pack.
Cod. B054
Medical device containing, as an active substance, magnesium peroxide (not less than 25% MgO 2 ) which develops oxygen in the gastrointestinal tract. This development of oxygen is accompanied by a significant reduction in intestinal germs which are present in high numbers in acute and chronic intestinal pathologies (dysbiosis).
Ozovit MP is therefore used in cases of gastrointestinal disorders caused by abnormal fermentation and putrefaction. Ozovit MP has been found to be effective as a preliminary disinfectant of the intestinal tract in cases of dysbiosis. In intestinal mycoses, specific antifungal treatment should precede the use of Ozovit MP, since the activity on fungi and protozoa has been found to be cytostatic.
Ozovit is a saline laxative with osmotic action. Since the absorption of magnesium peroxide is difficult, it results in water retention and an increase in water in the intestinal lumen. The intestinal contents become more voluminous, resulting in increased peristalsis.
Ozovit MP is indicated in episodes of occasional constipation and as a bowel movement aid before diagnostic tests or particular therapeutic treatments.
Composition
100 g contains: 100 g of magnesium peroxide.
How to use
Adults: 1 to 3 scoops of powder in water or fruit juice, 2 times a day 1 hour after meals.
In case of severe diarrhea, reduce the dosage or suspend treatment for 2-3 days. Then resume administration at a lower dosage.
Warnings
Ozovit MP should not be used for more than a week.
Do not take in case of renal insufficiency and intestinal obstruction (ileus). Do not take in case of known hypersensitivity to magnesium peroxide. Do not administer to children and adolescents. In rare cases, side effects may occur severe diarrhea with intestinal cramps and loss of electrolytes. These can be avoided by reducing the dosage.
Interactions with other drugs: in general, in order not to impair absorption, an interval of 1-2 hours must be respected between the administration of Ozovit MP and the following substances: iron, tetracyclines, sodium fluoride, isoniazid, chlorpromazine and digoxin.
As with other laxatives, prolonged intake of Ozovit MP can cause loss of water, potassium and other salts, resulting in cardiac function disorders and myasthenia. For this reason, the duration of administration should be limited to one week.
Format
100g pack.
Cod. B054
